Quote:
Originally Posted by dth123451
I would assume we'd contiue to fund the NIH at the same or greater levels, but if we're using the collective bargaining power of a single payer system to reduce the US's crazy over spending problem, we're going to see spending in the Phrama sector drop by something like 50-75% (all else being equal).
A lot of the money saved is going to go towards increased spending to cover more people and the increased bureaucracy (money that goes to places that arent ultimately R&D related) of dealing with 350M people, so we can't just shuffle it over to the NIH coffers.